S
Sachiko Matozaki
Publications - 8
Citations - 216
Sachiko Matozaki is an academic researcher. The author has contributed to research in topics: Somatic evolution in cancer & Chromosome 21. The author has an hindex of 4, co-authored 8 publications receiving 209 citations.
Papers
More filters
Journal ArticleDOI
Establishment of a myeloid leukaemic cell line (SKNO‐1) from a patient with t(8;21) who acquired monosomy 17 during disease progression
Sachiko Matozaki,Toshitaro Nakagawa,Ryuji Kawaguchi,Ryoji Aozaki,Masayoshi Tsutsumi,Tohru Murayama,Tamio Koizumi,Ryuichiro Nishimura,Takashi Isobe,Kazuo Chihara +9 more
TL;DR: A novel cell line SKNO‐1 was established from the bone marrow cells of a 22‐year‐old male suffering from acute myeloblastic leukaemia (AML) M2 with t(8;21) whose disease became resistant to chemotherapy after acquisition of 17 monosomy.
Journal ArticleDOI
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A
Tohru Murayarna,Shion Lmoto,Tetsuya Takahashi,Mitsuhiro Ito,Sachiko Matozaki,Toshitaro Nakagawa +5 more
TL;DR: It is demonstrated that cyclosporin A can be effective for treating angioimmunoblastic lymphadenopathy with dysproteinemia and complete remission was achieved in this patient, who still is in remission.
Journal ArticleDOI
Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome
Toshitaro Nakagawa,Sachiko Matozaki,Tohru Murayama,Ryuichiro Nishimura,Masayoshi Tsutsumi,Ryuji Kawaguchi,Yasunobu Yokoyama,Kazumasa Hikiji,Takashi Isobe,Kazuo Chihara +9 more
TL;DR: A cell line newly established from leukaemic cells of a 76‐year‐old Japanese male patient with monoblastic leukaemia following myelodysplastic syndrome, which has two mutations in p53 gene and overexpress the pS3 products may contribute to a better understanding of molecular mechanisms in the progression from MDS to myelogenousLeukaemia.
Journal ArticleDOI
The SKM-1 leukemic cell line established from a patient with progression to myelomonocytic leukemia in myelodysplastic syndrome (MDS)-contribution to better understanding of MDS.
TL;DR: Studying a leukemic cell line from the patient who initially possessed multiple point mutations of ras genes but lost these mutations during disease progression to myelomonocytic leukemia is a promising approach to understand the mechanisms of the initiation, disease progression, alterations of DNA repairment, and genetic instability in MDS and myelogenous malignancies.